PBH
Price
$72.70
Change
+$0.64 (+0.89%)
Updated
Mar 27, 6:59 PM EST
42 days until earnings call
TAK
Price
$13.84
Change
-$0.35 (-2.47%)
Updated
Mar 28, 12:10 PM EST
42 days until earnings call
Ad is loading...

PBH vs TAK ᐉ Comparison: Which is Better to Invest?

Header iconPBH vs TAK Comparison
Open Charts PBH vs TAKBanner chart's image
Prestige Consumer Healthcare
Price$72.70
Change+$0.64 (+0.89%)
Volume$68.12K
CapitalizationN/A
Takeda Pharmaceutical
Price$13.84
Change-$0.35 (-2.47%)
Volume$270
CapitalizationN/A
View a ticker or compare two or three
PBH vs TAK Comparison Chart

Loading...

PBHDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TAKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
PBH vs. TAK commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBH is a StrongBuy and TAK is a StrongSell.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (PBH: $72.63 vs. TAK: $14.19)
Brand notoriety: PBH and TAK are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: PBH: 87% vs. TAK: 92%
Market capitalization -- PBH: $3.61B vs. TAK: $45.47B
PBH [@Pharmaceuticals: Other] is valued at $3.61B. TAK’s [@Pharmaceuticals: Other] market capitalization is $45.47B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.16B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PBH’s FA Score shows that 1 FA rating(s) are green whileTAK’s FA Score has 2 green FA rating(s).

  • PBH’s FA Score: 1 green, 4 red.
  • TAK’s FA Score: 2 green, 3 red.
According to our system of comparison, TAK is a better buy in the long-term than PBH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PBH’s TA Score shows that 3 TA indicator(s) are bullish while TAK’s TA Score has 2 bullish TA indicator(s).

  • PBH’s TA Score: 3 bullish, 5 bearish.
  • TAK’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, PBH is a better buy in the short-term than TAK.

Price Growth

PBH (@Pharmaceuticals: Other) experienced а -1.04% price change this week, while TAK (@Pharmaceuticals: Other) price change was -2.47% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +9.14%. For the same industry, the average monthly price growth was +5.82%, and the average quarterly price growth was +14.04%.

Reported Earning Dates

PBH is expected to report earnings on May 09, 2024.

TAK is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (+9.14% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for PBH with price predictions.
OPEN
A.I.dvisor published
a Summary for TAK with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
TAK($45.5B) has a higher market cap than PBH($3.61B). TAK has higher P/E ratio than PBH: TAK (38.20) vs PBH (14.90). PBH YTD gains are higher at: 18.638 vs. TAK (-0.561). TAK has higher annual earnings (EBITDA): 1.01T vs. PBH (10.8M). TAK has more cash in the bank: 317B vs. PBH (63.6M). PBH has less debt than TAK: PBH (1.21B) vs TAK (4.66T). TAK has higher revenues than PBH: TAK (4.17T) vs PBH (1.13B).
PBHTAKPBH / TAK
Capitalization3.61B45.5B8%
EBITDA10.8M1.01T0%
Gain YTD18.638-0.561-3,324%
P/E Ratio14.9038.2039%
Revenue1.13B4.17T0%
Total Cash63.6M317B0%
Total Debt1.21B4.66T0%
FUNDAMENTALS RATINGS
PBH vs TAK: Fundamental Ratings
PBH
TAK
OUTLOOK RATING
1..100
7159
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
9
Undervalued
PROFIT vs RISK RATING
1..100
6100
SMR RATING
1..100
9144
PRICE GROWTH RATING
1..100
4568
P/E GROWTH RATING
1..100
6424
SEASONALITY SCORE
1..100
26n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (9) in the Pharmaceuticals Major industry is significantly better than the same rating for PBH (83) in the Pharmaceuticals Other industry. This means that TAK’s stock grew significantly faster than PBH’s over the last 12 months.

PBH's Profit vs Risk Rating (6) in the Pharmaceuticals Other industry is significantly better than the same rating for TAK (100) in the Pharmaceuticals Major industry. This means that PBH’s stock grew significantly faster than TAK’s over the last 12 months.

TAK's SMR Rating (44) in the Pharmaceuticals Major industry is somewhat better than the same rating for PBH (91) in the Pharmaceuticals Other industry. This means that TAK’s stock grew somewhat faster than PBH’s over the last 12 months.

PBH's Price Growth Rating (45) in the Pharmaceuticals Other industry is in the same range as TAK (68) in the Pharmaceuticals Major industry. This means that PBH’s stock grew similarly to TAK’s over the last 12 months.

TAK's P/E Growth Rating (24) in the Pharmaceuticals Major industry is somewhat better than the same rating for PBH (64) in the Pharmaceuticals Other industry. This means that TAK’s stock grew somewhat faster than PBH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PBHTAK
RSI
ODDS (%)
Bearish Trend 1 day ago
46%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
40%
Momentum
ODDS (%)
Bearish Trend 1 day ago
49%
Bearish Trend 1 day ago
54%
MACD
ODDS (%)
Bearish Trend 1 day ago
51%
Bearish Trend 1 day ago
53%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
51%
Bearish Trend 1 day ago
50%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
44%
Advances
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 11 days ago
44%
Declines
ODDS (%)
Bearish Trend 4 days ago
51%
Bearish Trend 17 days ago
45%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
64%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
59%
Bearish Trend 1 day ago
34%
View a ticker or compare two or three
Ad is loading...
PBHDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TAKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JGH12.920.27
+2.09%
NUVEEN GLOBAL HIGH Income FUND
NUSC41.400.79
+1.95%
Nuveen ESG Small-Cap ETF
TPIF27.290.13
+0.47%
Timothy Plan International ETF
PQDI18.660.02
+0.11%
Principal Spectrum Tax-Adv Dvd Actv ETF
FXE100.05-0.02
-0.02%
Invesco CurrencyShares® Euro Currency

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
+0.87%
PAHC - PBH
35%
Loosely correlated
+1.95%
IRWD - PBH
32%
Poorly correlated
+3.61%
EBS - PBH
26%
Poorly correlated
+6.15%
BGXX - PBH
24%
Poorly correlated
+5.69%
LFCR - PBH
24%
Poorly correlated
+0.39%
More